Norges Bank Eagle Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$15.21 - $22.88 $182,520 - $274,560
-12,000 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$17.74 - $31.87 $207,557 - $372,879
11,700 New
11,700 $227,000
Q1 2023

May 15, 2024
BUY
$25.06 - $34.09 $293,202 - $398,853
11,700 New
11,700 $331,000
Q4 2022

Feb 14, 2023
BUY
$24.98 - $39.77 $299,760 - $477,240
12,000 New
12,000 $350,000
Q3 2022

Nov 13, 2023
BUY
$26.42 - $47.12 $317,040 - $565,440
12,000 New
12,000 $317,000
Q2 2021

Aug 10, 2021
SELL
$36.86 - $44.5 $3.14 Million - $3.79 Million
-85,141 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$40.32 - $50.97 $3.43 Million - $4.34 Million
85,141 New
85,141 $3.55 Million
Q1 2021

May 07, 2021
SELL
$40.32 - $50.97 $6.94 Million - $8.78 Million
-172,174 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$41.72 - $51.34 $7.18 Million - $8.84 Million
172,174 New
172,174 $8.02 Million
Q4 2020

Feb 10, 2021
SELL
$41.72 - $51.34 $7.65 Million - $9.42 Million
-183,420 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$37.02 - $51.28 $6.79 Million - $9.41 Million
183,420 New
183,420 $7.79 Million
Q3 2020

Nov 10, 2020
SELL
$37.02 - $51.28 $8.11 Million - $11.2 Million
-218,937 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$43.24 - $55.02 $9.47 Million - $12 Million
218,937 New
218,937 $10.5 Million
Q2 2020

Aug 07, 2020
SELL
$43.24 - $55.02 $9.67 Million - $12.3 Million
-223,737 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$34.37 - $60.07 $7.69 Million - $13.4 Million
223,737 New
223,737 $10.3 Million
Q1 2020

May 08, 2020
SELL
$34.37 - $60.07 $8.53 Million - $14.9 Million
-248,179 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$54.32 - $64.31 $13.5 Million - $16 Million
248,179 New
248,179 $14.9 Million
Q4 2019

Feb 12, 2020
SELL
$54.32 - $64.31 $13.5 Million - $16 Million
-248,179 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$53.25 - $59.98 $13.2 Million - $14.9 Million
248,179 New
248,179 $14 Million
Q3 2019

Nov 08, 2019
SELL
$53.25 - $59.98 $13.2 Million - $14.9 Million
-248,179 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$46.61 - $58.45 $11.6 Million - $14.5 Million
248,179 New
248,179 $13.8 Million
Q2 2019

Aug 09, 2019
SELL
$46.61 - $58.45 $11.6 Million - $14.5 Million
-248,179 Closed
0 $0
Q1 2019

May 11, 2020
SELL
$38.66 - $51.82 $911,138 - $1.22 Million
-23,568 Reduced 8.67%
248,179 $12.5 Million
Q4 2018

Mar 04, 2019
BUY
$36.72 - $67.73 $9.98 Million - $18.4 Million
271,747 New
271,747 $10.9 Million
Q4 2018

Feb 08, 2019
SELL
$36.72 - $67.73 $6.43 Million - $11.9 Million
-175,201 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$66.65 - $83.86 $11.7 Million - $14.7 Million
175,201 New
175,201 $12.1 Million
Q3 2018

Nov 09, 2018
SELL
$66.65 - $83.86 $9.98 Million - $12.6 Million
-149,808 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$51.25 - $76.62 $7.68 Million - $11.5 Million
149,808 New
149,808 $11.3 Million
Q2 2018

Jul 23, 2018
SELL
$51.25 - $76.62 $4.67 Million - $6.98 Million
-91,117 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$52.16 - $66.86 $4.75 Million - $6.09 Million
91,117 New
91,117 $4.8 Million
Q1 2018

May 09, 2018
SELL
$52.16 - $66.86 $4.75 Million - $6.09 Million
-91,117 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$49.6 - $60.87 $4.52 Million - $5.55 Million
91,117 New
91,117 $4.87 Million
Q4 2017

Feb 09, 2018
SELL
$49.6 - $60.87 $3.61 Million - $4.43 Million
-72,713 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$46.62 - $60.36 $3.39 Million - $4.39 Million
72,713 New
72,713 $4.34 Million
Q3 2017

Nov 07, 2017
SELL
$46.62 - $60.36 $6.39 Million - $8.27 Million
-137,077 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
21,463 Added 18.56%
137,077 $10.8 Million
Q1 2017

May 11, 2018
BUY
N/A
44,606 Added 62.82%
115,614 $9.59 Million
Q3 2016

Nov 13, 2017
BUY
N/A
71,008
71,008 $0

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email